Medical/Pharmaceuticals News & Press Release Distribution

PharmAbcine Announces Encouraging Non-clinical Data of PMC-403 at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting

DAEJEON, South Korea, May 10, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of antibody therapeutics, announced today that the company presented an e-poster featuring non-clinical data of PMC-403 at the Association for Resea...

2021-05-10 20:00 1842

Thrombectomy Stroke Treatment Reversing Paralysis and Preventing Death Gets Its Global Day

The first annual "World Stroke Thrombectomy Day" is declared on May 15, 2021 by The Society of Vascular and Interventional Neurology Mission Thrombectomy 2020+ Initiative. MINNEAPOLIS, May 10, 2021 /PRNewswire/ -- The Society of Vascular and Interventional Neurology (SVIN) Mission Thrombectomy 2...

2021-05-10 20:00 1341

INOVIO Announces Positive Data from Phase 2 Segment of Clinical Trial Evaluating INO-4800, its COVID-19 DNA Vaccine

PLYMOUTH MEETING, Pa., May 10, 2021 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases, today announced positive safety, tolerability ...

2021-05-10 20:00 4193

Viva Biotech and BioMap Reached a Strategic Collaboration Agreement, To Jointly Accelerate the Early Drug Discovery through AI Technology

SHANGHAI, May 10, 2021 /PRNewswire/ -- Hosted by BioMap and Adock, the first generation of China Biocomputing Conference was successfully launched in Suzhou. The conference is aiming to unite with biotech and IT industry partners to create a multi-party integrated industrial ecosystem, and realiz...

2021-05-10 18:21 2987

Bionomics BNC210 Expansion into Social Anxiety Disorder

* Rapid oral absorption of BNC210 novel tablet formulation ideally suited for acute treatment of anxiety in patients with Social Anxiety Disorder * BNC210 Phase 2b PTSD trial on target for start in mid-2021 with U.S. CRO Premier Research selected and clinical site identification underway * P...

2021-05-10 18:00 3723

Invitation to the presentation of Elekta's fiscal year 2020/21

STOCKHOLM, May 10, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) invites analysts and investors to a presentation of the fiscal year 2020/21 at10:00 a.m. CEST on May 28. The year-end report will be published at 7:30 a.m. CET on the same day.The company's development will be presented by Elekta's Presid...

2021-05-10 17:43 2597

CAPA-IVM a promising advance in assisted reproduction for women with PCOS

SINGAPORE, May 10, 2021 /PRNewswire/ -- The first births and on-going well-being of babies born from an advanced assisted reproduction process called CAPA in-vitro oocyte maturation, or IVM, has highlighted the potential of the procedure for millions of women with complex fertility issues includi...

2021-05-10 13:00 2200

Hong Kong government endorses INDICAID(R) in visitation resumption arrangements

HONG KONG, May 10, 2021 /PRNewswire/ -- COVID-19 rapid antigen test (RAT) INDICAID®, developed by Hong Kong biotechnology start-up PHASE Scientific International Limited (PHASE), has been named by the government as one of the designated rapid tests when care homes resume visitation today. The end...

2021-05-10 11:30 1936

New focus on male factors critical for success in human fertility treatment

SINGAPORE, May 10, 2021 /PRNewswire/ -- The adverse impact of male factors in assisted reproductive treatments was brought into a clear and disturbing focus at the 10th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE). The ASPIRE Congress, originally to be held in the Philippine...

2021-05-10 10:06 1649

Hong Kong government endorses INDICAID(R) in visitation resumption arrangements

HONG KONG, May 10, 2021 /PRNewswire/ -- COVID-19 rapid antigen test (RAT) INDICAID®, developed by Hong Kong biotechnology start-up PHASE Scientific International Limited (PHASE), has been named by the government as one of the designated rapid tests when care homes resume visitation today. The end...

2021-05-10 10:00 2119

Hong Kong Government Endorses INDICAID® in Visitation Resumption Arrangements

HONG KONG, May 10, 2021 /PRNewswire/ -- COVID-19 rapid antigen test (RAT) INDICAID®, developed by Hong Kong biotechnology start-up PHASE Scientific International Limited (PHASE), has been named by the government as one of the designated rapid tests when care homes resume visitation today. The end...

2021-05-10 09:36 3982

Alebund Pharmaceuticals Raises $60 million in Series B Financing Round to Accelerate Its Development of Innovative Drugs and Total Solutions for the Treatment of Renal Diseases

SHANGHAI, May 9, 2021 /PRNewswire/ -- Alebund Pharmaceuticals ("Alebund" or the "Company"), a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases and related chronic conditions, today announced that it has raised$60 million in its Series B fi...

2021-05-10 08:13 1820

Improving access and affordability of fertility treatment in low to middle income countries

SINGAPORE, May 8, 2021 /PRNewswire/ -- Mounting concerns about access to infertility treatment in low to middle income countries and measures to address the problem have come into sharp focus at the 10th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE). Countries including Indo...

2021-05-08 15:09 3005

Daewoong showed improved performance both sales and earnings in Q1

* OP. income exceeded 20 billion won due to successful export of Fexuprazan and sales recovery * Nabota(botulinum toxin) revenue soared after settlement, historical high performance in March * Turnaround in earnings just started and will continue to 2H SEOUL, South Korea, May 7, 2021 /PRNew...

2021-05-07 21:00 5239

Vakrangee Enters The Online Space With The Launch Of Digital Services

- Through this, company has evolved into the unique O2O (Online to Offline) platform, whereby there is Assistance available through the 10,000+ Physical Kendra store network along with Digital Online Services - Initiated this Unique Hybrid proposition with launch of first Digital service of Tele...

2021-05-07 14:08 4440

WuXi Biologics Completed Three Acquisitions to Enhance its Global Network

SHANGHAI, May 7, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has completed the acquisitions of a Bayer manufacturing facility in Wuppertal,Germany, the Pfizer China ("Pfizer") manufacturing...

2021-05-07 08:30 5764

The Biofactory To Convert Hospital Facilities Into Isolation Facilities Under Master Agreement Signed

SINGAPORE, May 7, 2021 /PRNewswire/ -- The Biofactory has signed a master supply and servicing agreement with ALPS Pte. Ltd, the public healthcare supply chain agency, to be able to provide portable prefabricated negative pressure anterooms to local public healthcare and research institutions etc...

2021-05-07 08:05 3357

Nexturn Bio Inc. decided to invest in the development of a new drug pipeline for diabetes treatment using miRNA

SEOUL, South Korea, May 7, 2021 /PRNewswire/ -- Nexturn Bio Inc., a subsidiary of Nexturn Bioscience Co., Ltd. (KOSDAQ:89140), said it has secured a 50% stake in RosVivo Therapeutics Inc., a U.S. new drug developer, as its first investment destination. RosVivo recently developed RSVI-301, a new d...

2021-05-07 07:00 6362

Nexturn Bio Inc. decided to invest in the development of a new drug pipeline for diabetes treatment using miRNA

Communique from annual general meeting in Mentice AB (publ)

STOCKHOLM, May 7, 2021 /PRNewswire/ -- An annual general meeting was held in Mentice AB on6 May 2021. Below follows a summary of the resolutions made at the meeting. Adoption of the income statement and the balance sheet, the consolidated income statement and the consolidated balance sheet and d...

2021-05-07 01:46 1856

COVID-19 has caused 6.9 million deaths globally, more than double what official reports show

SEATTLE, May 6, 2021 /PRNewswire/ -- Globally, COVID-19 has caused approximately 6.9 million deaths, more than double what official numbers show, according toa new analysis by the Institute for Health Metrics and Evaluation (IHME) at theUniversity of Washington School of Medicine. IHME found that...

2021-05-06 23:00 3821